Clinical Trial Update: Etodolac and Post-bleaching Sensitivity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating etodolac for post-bleaching dental sensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Etodolac (Etodolac)

Snippet

Sponsor: Flavia Pardo Salata Nahsan | Conditions: Medicaments Substances in Therapeutic Use | Phase 4 | Status: COMPLETED